CrossrefInfokarte
Safety and efficacy of the FOLFOX regimen in patients with metastatic gastrointestinal cancers and severe hyperbilirubinemia: A real‑world experience
Oncology Letters · 2026-10-30 · 32 (6) · 1-9
DOI: 10.3892/ol.2026.15932 ↗Abstract
Kein Abstract verfügbar.
EUVIMED